Chief Operating Officer
Justin To is the Chief Operating Officer of BridgeBio Gene Therapy (BBGT). He previously served as Vice President of Business Development and Operations at BBGT. Justin leads BBGT’s program management, in-licensing, company creation, and partnering activities. He is passionate about developing novel gene therapies for diseases with significant unmet need. Previously, Justin was a Product Commercialization Manager at Flatiron Health and a consultant in the healthcare practice at McKinsey & Company. Justin has a AB in Chemistry, Magna Cum Laude with Highest Honors, from Harvard College.